About this trial
Incompatibility between evidence-based treatments (EBTs) and the cultural values, practices, and minoritized experiences of Latine youth and families contributes to racial-ethnic disparities in mental health treatment engagement and consequently mental health outcomes. The proposed study aims to develop and pilot a novel tool - the Culturally Responsive Assessment, Formulation, and Treatment Tool (CRAFTT) - for helping clinicians decide whether, when, and how to culturally adapt EBTs for individual Latine youth clients and thereby improve the cultural compatibility of EBTs for this underserved population. Completion of this study will result in a functional decision support tool designed to improve the quality and effectiveness of mental health services for Latine youths and promote mental health equity.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Identify as Latino
Fluent in English or Spanish
5-15 years old
Referred to individual psychotherapy with a participating clinician for a primary clinical concern involving anxiety, depression, trauma, or disruptive behaviors
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Culturally Responsive Assessment, Formulation, and Treatment Tool (CRAFTT)
Other interventionCRAFTT will help clinicians assess whether their client is engaged and progressing, diagnose cultural risk and resilience factors, plan to implement cultural adaptations, implement cultural adaptations, and (re)evaluate client engagement and progress.
Cultural Formulation Interview
Diagnostic testThe Cultural Formulation Interview is a 16-item semi-structured interview that is organized into four sections: (i) definition of the problem; (ii) perceptions of cause, context, and support; (iii) factors affecting self-coping and past help seeking; and (iv) factors affecting current help seeking.
Modular Approach to Therapy for Children
BehavioralThe Modular Approach to Therapy for Children is a modular evidence-based treatment for youths, aged 5-15, with anxiety, depression, trauma, and disruptive behaviors.
Treatment groups
Trial outcomes
Primary outcomes
DSM-5 Cross-Cutting Symptom Measure
24-item self-report questionnaire that assesses symptoms across psychiatric diagnoses
Secondary outcomes
Revised Anxiety and Depression Scale
25-item self-report questionnaire that assesses symptoms of anxiety
Strengths and Difficulties Questionnaire
25-item self-report questionnaire that assesses psychopathology
UCLA PTSD Reaction Index
22-item self-repot questionnaire that assesses symptoms of traumatic stress
Columbia Impairment Scale
13-item self-report questionnaire that assesses impairment
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: